Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Cohn

Showing results (171-180 of 302) with videos related to

Pageof 31
Sort By:
Gynecologic Oncology|December 3, 2014
The cost-effectiveness of selective lymphadenectomy based on a preoperative prediction model in patients with endometrial cancer: insights from the US and Korean healthcare systemsJung-Yun Lee, David E Cohn, Younhee Kim, et al.
AJOG Global Reports|October 24, 2022
Wound complications following vulvar excision for nonmalignant lesionsGlenn P Boyles, Ashlee M Weaver, David E Cohn, et al.
Familial Cancer|July 31, 2009
Are prediction models for Lynch syndrome valid for probands with endometrial cancer?Floor J Backes, Heather Hampel, Katherine A Backes, et al.
Gynecologic Oncology|July 20, 2014
Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitorBrent J Tierney, Georgia A McCann, Shan Naidu, et al.
Gynecologic Oncology|March 6, 2012
Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer stagingFloor J Backes, Lorna A Brudie, M Ryan Farrell, et al.
Cancer|March 2, 2024
Reply to "Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy"Courtney J Riedinger, Ashwini Esnakula, Paulina J Haight, et al.
Gynecologic Oncology|July 29, 2015
Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer CenterMargaret I Liang, Adam C ElNaggar, Silpa Nekkanti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2016
Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective CohortFloor J Backes, Adam C ElNaggar, Michael Ryan Farrell, et al.
American Journal of Obstetrics and Gynecology|August 12, 2019
Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasiaMonica Hagan Vetter, Blair Smith, Jason Benedict, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2013
Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?Floor J Backes, Debra L Richardson, Georgia A McCann, et al.
Pageof 31

Showing results (171-180 of 302) with videos related to

Sort By:
Pageof 31
Gynecologic Oncology|December 3, 2014
The cost-effectiveness of selective lymphadenectomy based on a preoperative prediction model in patients with endometrial cancer: insights from the US and Korean healthcare systemsJung-Yun Lee, David E Cohn, Younhee Kim, et al.
AJOG Global Reports|October 24, 2022
Wound complications following vulvar excision for nonmalignant lesionsGlenn P Boyles, Ashlee M Weaver, David E Cohn, et al.
Familial Cancer|July 31, 2009
Are prediction models for Lynch syndrome valid for probands with endometrial cancer?Floor J Backes, Heather Hampel, Katherine A Backes, et al.
Gynecologic Oncology|July 20, 2014
Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitorBrent J Tierney, Georgia A McCann, Shan Naidu, et al.
Gynecologic Oncology|March 6, 2012
Short- and long-term morbidity and outcomes after robotic surgery for comprehensive endometrial cancer stagingFloor J Backes, Lorna A Brudie, M Ryan Farrell, et al.
Cancer|March 2, 2024
Reply to "Mismatch repair and microsatellite instability-Recommendation for an optimal test strategy"Courtney J Riedinger, Ashwini Esnakula, Paulina J Haight, et al.
Gynecologic Oncology|July 29, 2015
Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer CenterMargaret I Liang, Adam C ElNaggar, Silpa Nekkanti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 31, 2016
Perioperative Outcomes for Laparotomy Compared to Robotic Surgical Staging of Endometrial Cancer in the Elderly: A Retrospective CohortFloor J Backes, Adam C ElNaggar, Michael Ryan Farrell, et al.
American Journal of Obstetrics and Gynecology|August 12, 2019
Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasiaMonica Hagan Vetter, Blair Smith, Jason Benedict, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2013
Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?Floor J Backes, Debra L Richardson, Georgia A McCann, et al.
Pageof 31